Equillium Inc (EQ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $94.67M
Last updated: Nov 17, 2026 at 4:10 PM ET
Equillium Inc (EQ) Statistics
Equillium (EQ) has a market cap of $94.67M. Its share count is up 213.34% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $94.67M |
|---|---|
| Latest price (Nov 17, 2026) | $1.21 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 30.8x and 2.6x. Its year-end P/S ranged from 0.7x to 2.3x from 2022 to 2024.
| P/S Ratio | 30.8x |
|---|---|
| P/B Ratio | 2.6x |
Price Statistics
The stock is up 16.35% over 52 weeks and trades 21.43% below its 50-day average.
| Beta (1Y) | 1.32 |
|---|---|
| 52-Week Change | +16.35% |
| 1-Month Change | -2.42% |
| 3-Month Change | -48.07% |
| 6-Month Change | -31.44% |
| 5-Year Change | -78.29% |
| Total Return (1Y) | +16.35% |
| Total Return (5Y CAGR) | -25.31% |
| Return vs SPY (1Y) | +9.44% |
| Max Drawdown (1Y) | -64.06% |
| Max Drawdown (3Y) | -90.33% |
| Sharpe Ratio (1Y) | 0.19 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $1.54 |
| 200-Day Average | $2.08 |
| 52-Week Range | $0.81 to $3.54 |
| RSI (14 Days) | 38.8 |
| Average Volume (20 Days) | 305.26K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 19.49x current liabilities.
| Current Ratio | 19.49x |
|---|---|
| Quick Ratio | 19.49x |
Returns and Efficiency
Return on equity is -34.86% over the last 12 months, against a 5-year average of -86.75%.
| Return on Equity (ROE) | -34.86% |
|---|---|
| Return on Assets (ROA) | -32.90% |
| ROE (5Y Average) | -86.75% |
| ROA (5Y Average) | -50.68% |
| ROIC (5Y Average) | -66.60% |
Scores
EQ has an Altman Z-Score of 20.24, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 20.24 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$19.77M |
| Pretax Income | -$18.36M |
| Net Income | -$18.36M |
| Reported EPS (TTM) | -$0.18 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 94.39% of the $55.81M in total assets.
| Cash and Equivalents | $53.32M |
|---|---|
| Working Capital | $52.13M |
| Shareholder Equity | $52.68M |
| Book Value Per Share | $0.47 |
| Total Assets | $55.81M |
| Total Liabilities | $3.13M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $118.00K of capital spending, operating cash flow left -$15.48M of free cash flow.
| Operating Cash Flow | -$15.37M |
|---|---|
| Capital Expenditures | $118.00K |
| Free Cash Flow | -$15.48M |
| FCF Per Share | -$0.19 |
| Depreciation and Amortization | $97.00K |
Trailing 12 months through Sep 30, 2026.
Growth
Revenue fell 79.79% a year over 3 years.
| Revenue Growth (3Y CAGR) | -79.79% |
|---|---|
| Book Value Per Share Growth (2Y CAGR) | -30.38% |
| Tangible Book Per Share Growth (2Y CAGR) | -30.38% |
Peer Position
Against 5 similar companies, EQ has the 2nd highest P/S.
P/S RatioPeer median 4.0x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -82.16%
| P/S Ratio | 30.8x vs 4.0x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs -82.16% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About EQ
What is EQ's market cap?
Equillium has a market cap of $94.67M.
How many shares of EQ are outstanding?
Equillium has 111.92M shares outstanding. The count is up 213.34% from a year earlier.
Does EQ pay a dividend?
No. Equillium does not pay a dividend.
EQ pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors